REPORTS

Let’s Pullulate and Expand Your Business

Prostate Cancer Market - Global Professional Analysis and Forecast to 2026

Oct 21, 2019  |  197 PAGES  |  REPORT CODE: CMM220251
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Prostate Cancer market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.1% during the forecast period.

This report presents the market size and development trends by detailing the Prostate Cancer market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Prostate Cancer market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Prostate Cancer industry and will help you to build a panoramic view of the industrial development.

Prostate Cancer Market, By Type:

  • Hormonal Therapy

  • Chemotherapy

  • Targeted Therapy

  • Immunotherapy

Prostate Cancer Market, By Application:

  • Hospital Pharmacy

  • Retail Pharmacy

  • Online Pharmacy

Some of the leading players are as follows:

  • Astellas Pharma Inc.

  • Sanofi

  • Ferring BV

  • Abbott

  • Cellanyx LLC

  • TOLMAR Pharmaceuticals Inc.

  • Bayer AG

  • Dendreon Inc.

  • AstraZeneca

  • BioMark Diagnostics Inc.

  • Indevus Pharmaceuticals Inc.

  • Ipsen

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Prostate Cancer Market: Technology Type Analysis

  • 4.1 Prostate Cancer Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Prostate Cancer Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Hormonal Therapy

    • 4.3.2 Chemotherapy

    • 4.3.3 Targeted Therapy

    • 4.3.4 Immunotherapy

5 Prostate Cancer Market: Product Analysis

  • 5.1 Prostate Cancer Product Market Share Analysis, 2018 & 2026

  • 5.2 Prostate Cancer Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Prostate Cancer Market: Application Analysis

  • 6.1 Prostate Cancer Application Market Share Analysis, 2018 & 2026

  • 6.2 Prostate Cancer Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospital Pharmacy

    • 6.3.2 Retail Pharmacy

    • 6.3.3 Online Pharmacy

7 Prostate Cancer Market: Regional Analysis

  • 7.1 Prostate Cancer Regional Market Share Analysis, 2018 & 2026

  • 7.2 Prostate Cancer Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Astellas Pharma Inc.

    • 9.1.1 Astellas Pharma Inc. Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Sanofi

    • 9.2.1 Sanofi Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Ferring BV

    • 9.3.1 Ferring BV Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Abbott

    • 9.4.1 Abbott Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Cellanyx LLC

    • 9.5.1 Cellanyx LLC Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 TOLMAR Pharmaceuticals Inc.

    • 9.6.1 TOLMAR Pharmaceuticals Inc. Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Bayer AG

    • 9.7.1 Bayer AG Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Dendreon Inc.

    • 9.8.1 Dendreon Inc. Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 AstraZeneca

    • 9.9.1 AstraZeneca Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 BioMark Diagnostics Inc.

    • 9.10.1 BioMark Diagnostics Inc. Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Indevus Pharmaceuticals Inc.

    • 9.11.1 Indevus Pharmaceuticals Inc. Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Ipsen

    • 9.12.1 Ipsen Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

 

The List of Tables and Figures (Totals 74 Figures and 157 Tables)

  • Figure Hormonal Therapy Prostate Cancer market, 2015 - 2026 (USD Million)

  • Figure Chemotherapy Prostate Cancer market, 2015 - 2026 (USD Million)

  • Figure Targeted Therapy Prostate Cancer market, 2015 - 2026 (USD Million)

  • Figure Immunotherapy Prostate Cancer market, 2015 - 2026 (USD Million)

  • Figure Hospital Pharmacy market, 2015 - 2026 (USD Million)

  • Figure Retail Pharmacy market, 2015 - 2026 (USD Million)

  • Figure Online Pharmacy market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Prostate Cancer market, by country, 2015 - 2026 (USD Million)

  • Table North America Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table North America Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table North America Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table Canada Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table Canada Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Europe Prostate Cancer market, by country, 2015 - 2026 (USD Million)

  • Table Europe Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table Europe Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table Europe Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table Germany Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table Germany Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table France Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table France Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table Italy Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table Italy Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table Spain Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table Spain Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Prostate Cancer market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table China Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table China Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table Japan Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table Japan Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table India Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table India Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Prostate Cancer market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table MEA Prostate Cancer market, by country, 2015 - 2026 (USD Million)

  • Table MEA Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table MEA Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table MEA Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Prostate Cancer market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Prostate Cancer market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Prostate Cancer market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Astellas Pharma Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ferring BV Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cellanyx LLC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table TOLMAR Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Dendreon Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BioMark Diagnostics Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Indevus Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ipsen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top